183 related articles for article (PubMed ID: 16715105)
1. A case of hepatic graft-versus-host disease complicating autologous stem cell transplantation for relapsed Hodgkin's disease.
Cutting R; Wright J; Underwood J
Bone Marrow Transplant; 2006 Jul; 38(1):77-8. PubMed ID: 16715105
[No Abstract] [Full Text] [Related]
2. Treatment of severe life-threatening graft-versus-host disease by autologous peripheral blood stem cell transplantation using a nonmyeloablative preconditioning regimen.
Taniguchi Y; Ikegame K; Yoshihara S; Sugiyama H; Kawase I; Ogawa H
Haematologica; 2003 Mar; 88(3):ELT06. PubMed ID: 12651288
[No Abstract] [Full Text] [Related]
3. A case of sclerodermatous graft-versus-host disease following autologous peripheral blood stem cell transplantation.
Nakamura K; Kawakami Y; Oyama N; Kaneko F; Abe H; Sagara H; Ohto H
J Dermatol; 2006 Feb; 33(2):135-8. PubMed ID: 16556284
[TBL] [Abstract][Full Text] [Related]
4. Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusion.
Todisco E; Castagna L; Sarina B; Mazza R; Anastasia A; Balzarotti M; Banna G; Tirelli U; Soligo D; Santoro A
Eur J Haematol; 2007 Apr; 78(4):322-9. PubMed ID: 17253967
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal chronic graft-versus-host disease: management options.
Awan F; Hamadani M
J Oncol Pharm Pract; 2007 Mar; 13(1):49-51. PubMed ID: 17621568
[TBL] [Abstract][Full Text] [Related]
6. Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Sureda A; Robinson S; Canals C; Carella AM; Boogaerts MA; Caballero D; Hunter AE; Kanz L; Slavin S; Cornelissen JJ; Gramatzki M; Niederwieser D; Russell NH; Schmitz N
J Clin Oncol; 2008 Jan; 26(3):455-62. PubMed ID: 18086796
[TBL] [Abstract][Full Text] [Related]
7. High-dose therapy and autologous stem cell transplantation for Hodgkin's lymphoma in relapse or failure after initial chemotherapy : results of the Centre National de Greffe de Moelle Osseuse de Tunis.
Torjman L; Ladeb S; Lakhal A; Ben Othman T; Abdelkefi A; Ben Abdeladhim A
Tunis Med; 2007 Jan; 85(1):35-8. PubMed ID: 17424707
[TBL] [Abstract][Full Text] [Related]
8. Autologous stem cell transplantation with selected CD34+ cells and unmanipulated peripheral blood stem cells in patients with relapsed and refractory Hodgkin's lymphoma: a single centre experience.
Ballova V; Ladicka M; Vranovsky A; Lakota J
Neoplasma; 2008; 55(5):428-36. PubMed ID: 18665754
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Hodgkin's disease.
Introcaso CE; Kantor J; Porter DL; Junkins-Hopkins JM
J Am Acad Dermatol; 2008 Feb; 58(2):295-8. PubMed ID: 18222326
[TBL] [Abstract][Full Text] [Related]
10. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
[TBL] [Abstract][Full Text] [Related]
11. Nonconvulsive status epilepticus associated with cefepime in a patient undergoing autologous stem cell transplantation.
Plensa E; Gallardo E; Ribera JM; Batlle M; Oriol A; Costa J
Bone Marrow Transplant; 2004 Jan; 33(1):119-20. PubMed ID: 14704665
[No Abstract] [Full Text] [Related]
12. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
13. Granuloma annulare on herpes zoster scars in a Hodgkin's disease patient following autologous peripheral stem cell transplantation.
Sanli HE; Koçyiğit P; Arica E; Kurtyüksel M; Heper AO; Ozcan M
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):314-7. PubMed ID: 16503895
[TBL] [Abstract][Full Text] [Related]
14. Nephrotic syndrome in a patient with relapsed of chronic myeloid leukemia after peripheral blood stem cell transplantation.
Bee PC; Gan GG; Sangkar VJ; Haris AR
Med J Malaysia; 2008 Mar; 63(1):71-2. PubMed ID: 18935742
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?
Burt RK; Testori A; Craig R; Cohen B; Suffit R; Barr W
J Autoimmun; 2008 May; 30(3):116-20. PubMed ID: 18242956
[TBL] [Abstract][Full Text] [Related]
16. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R
Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430
[TBL] [Abstract][Full Text] [Related]
17. Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab.
Benson DM; Smith MK; Krugh D; Devine SM
Bone Marrow Transplant; 2008 Mar; 41(6):595-6. PubMed ID: 18037934
[No Abstract] [Full Text] [Related]
18. Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma.
Benekli M; Smiley SL; Younis T; Czuczman MS; Hernandez-Ilizaliturri F; Bambach B; Battiwalla M; Padmanabhan S; McCarthy PL; Hahn T
Bone Marrow Transplant; 2008 Apr; 41(7):613-9. PubMed ID: 18071290
[TBL] [Abstract][Full Text] [Related]
19. LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre.
Perz JB; Giles C; Szydlo R; O'Shea D; Sanz J; Chaidos A; Wagner S; Davis J; Loaiza S; Marin D; Apperley J; Olavarria E; Rahemtulla A; Lampert I; Naresh K; Samson D; MacDonald D; Kanfer EJ
Bone Marrow Transplant; 2007 Jan; 39(1):41-7. PubMed ID: 17115062
[TBL] [Abstract][Full Text] [Related]
20. Acute graft versus host disease.
Kumawat MK; Khandpur S
Indian J Dermatol Venereol Leprol; 2011; 77(2):217-9. PubMed ID: 21393964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
